Mdm2 promotes genetic instability and transformation independent of p53

被引:81
|
作者
Bouska, Alyssa [2 ]
Lushnikova, Tamara [1 ]
Plaza, Silvia [2 ]
Eischen, Christine A. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
[2] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA
关键词
D O I
10.1128/MCB.01584-07
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mdm2, a regulator of the tumor suppressor p53, is frequently overexpressed in human malignancies. Mdm2 also has unresolved, p53-independent functions that contribute to tumorigenesis. Here, we show that increased Mdm2 expression induced chromosome/chromatid breaks and delayed DNA double-strand break repair in cells lacking p53 but not in cells with a mutant form of Nbs1, a component of the Mre11/Rad50/Nbs1 DNA repair complex. A 31-amino-acid region of Mdm2 was necessary for binding to Nbs1. Mutation of conserved amino acids in the Nbs1 binding domain of Mdm2 inhibited Mdm2-Nbs1 association and prevented Mdm2 from delaying phosphorylation of H2AX and ATM-S/TQ sites, repair of DNA breaks, and resolution of DNA damage foci. Similarly, the mutation of eight amino acids in the Mdm2 binding domain of Nbs1 inhibited Mdm2-Nbs1 interaction and blocked the ability of Mdm2 to delay DNA break repair. Both Nbs1 and ATM, but not the ubiquitin ligase activity of Mdm2, were necessary to inhibit DNA break repair. Only Mdm2 with an intact Nbs1 binding domain was able to increase the frequency of chromosome/chromatid breaks and the transformation efficiency of cells lacking p53. Therefore, the interaction of Mdm2 with Nbs1 inhibited DNA break repair, leading to chromosome instability and subsequent transformation that was independent of p53.
引用
收藏
页码:4862 / 4874
页数:13
相关论文
共 50 条
  • [1] Mdmx promotes genomic instability independent of p53 and Mdm2
    Carrillo, A. M.
    Bouska, A.
    Arrate, M. P.
    Eischen, C. M.
    ONCOGENE, 2015, 34 (07) : 846 - 856
  • [2] Mdmx promotes genomic instability independent of p53 and Mdm2
    A M Carrillo
    A Bouska
    M P Arrate
    C M Eischen
    Oncogene, 2015, 34 : 846 - 856
  • [3] Mdm2 promotes the rapid degradation of p53
    Ygal Haupt
    Ruth Maya
    Anat Kazaz
    Moshe Oren
    Nature, 1997, 387 : 296 - 299
  • [4] Mdm2 promotes the rapid degradation of p53
    Haupt, Y
    Maya, R
    Kazaz, A
    Oren, M
    NATURE, 1997, 387 (6630) : 296 - 299
  • [5] Mdm2 Affects Genome Stability Independent of p53
    Bouska, Alyssa
    Eischen, Christine M.
    CANCER RESEARCH, 2009, 69 (05) : 1697 - 1701
  • [6] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678
  • [7] MDM2与p53
    金晶
    刘耕陶
    癌症, 2001, (06) : 663 - 666
  • [8] MDM2 and BCL-2: to p53 or not to p53?
    Wang, Eunice S.
    BLOOD, 2023, 141 (11) : 1237 - 1238
  • [9] Binding of an inhibitor of the p53/MDM2 interaction to MDM2
    Duncan, SJ
    Cooper, MA
    Williams, DH
    CHEMICAL COMMUNICATIONS, 2003, (03) : 316 - 317
  • [10] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Christine Wasylyk
    Roberto Salvi
    Manuela Argentini
    Christine Dureuil
    Isabelle Delumeau
    Joseph Abecassis
    Laurent Debussche
    Bohdan Wasylyk
    Oncogene, 1999, 18 : 1921 - 1934